Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
APGE
#1241
Apogee Therapeutics, Inc. Common Stock
70.000
0
+1.13%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+1.13%
Monthly Change
-3.86%
6 month change
+30.62%
Cambio anual
+30.62%
Cierres anteriores
69.215
0
Open
70.000
0
Bid
Ask
Low
70.000
0
High
70.000
0
Volumen
87
Markets
Acciones
Atención Sanitaria
APGE
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Apogee Therapeutics: Jefferies reduziert Kursziel aufgrund von OX40-Risiken
Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns
Intel, Iris Energy among market cap stock movers on Friday
Intel and AMD among market cap stock movers on Friday
Thursday’s Insider Activity: GameStop CEO’s $21M Buy Stands Out
Apogee Therapeutics: RBC Capital stuft Aktie wegen hoher Bewertung herab
Apogee Therapeutics stock downgraded by RBC Capital on valuation concerns
Deutsche Bank: Diese US-Biopharma-Aktien stehen 2026 vor starkem Wachstum
Top US Biopharma Stocks Poised for Growth in 2026, According to Deutsche Bank
CEO von Apogee Therapeutics veräußert Aktienpaket im Wert von 1,6 Mio. Dollar
Apogee Therapeutics CEO Henderson sells $1.6m in stock
Apogee Therapeutics auf Rekordhoch: Aktie erreicht 81,0 USD